Trial Outcomes & Findings for A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation (NCT NCT03255824)

NCT ID: NCT03255824

Last Updated: 2020-05-13

Results Overview

To compare the groups regarding the number of respiratory events requiring intervention, described as: Chin lift/jaw thrust, Tongue thrust, Yankauer suctioning, Positive pressure oxygen administration, Placement of an oral or nasal airway.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

144 participants

Primary outcome timeframe

During surgery

Results posted on

2020-05-13

Participant Flow

Participant milestones

Participant milestones
Measure
Propofol Group
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Overall Study
STARTED
69
75
Overall Study
COMPLETED
67
74
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Propofol Group
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Overall Study
Under-sedation
2
1

Baseline Characteristics

Race/Ethnicity Not Collected

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Propofol Group
n=69 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=75 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Total
n=144 Participants
Total of all reporting groups
Age, Continuous
21.3 years
STANDARD_DEVIATION 2.7 • n=69 Participants
21.4 years
STANDARD_DEVIATION 2.5 • n=75 Participants
21.4 years
STANDARD_DEVIATION 2.7 • n=144 Participants
Sex: Female, Male
Female
50 Participants
n=69 Participants
46 Participants
n=75 Participants
96 Participants
n=144 Participants
Sex: Female, Male
Male
19 Participants
n=69 Participants
29 Participants
n=75 Participants
48 Participants
n=144 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Race/Ethnicity Not Collected
0 Participants
Race/Ethnicity Not Collected
0 Participants
Race/Ethnicity Not Collected
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Race/Ethnicity Not Collected
0 Participants
Race/Ethnicity Not Collected
0 Participants
Race/Ethnicity Not Collected
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race/Ethnicity Not Collected
0 Participants
Race/Ethnicity Not Collected
0 Participants
Race/Ethnicity Not Collected
Body Mass Index (BMI)
25.3 kg/m^2
STANDARD_DEVIATION 5.2 • n=69 Participants
26.1 kg/m^2
STANDARD_DEVIATION 5.4 • n=75 Participants
25.7 kg/m^2
STANDARD_DEVIATION 5.4 • n=144 Participants
Number of Impactions
3.6 Impacted Teeth
STANDARD_DEVIATION 0.5 • n=69 Participants
3.6 Impacted Teeth
STANDARD_DEVIATION 0.5 • n=75 Participants
3.6 Impacted Teeth
STANDARD_DEVIATION 0.5 • n=144 Participants

PRIMARY outcome

Timeframe: During surgery

To compare the groups regarding the number of respiratory events requiring intervention, described as: Chin lift/jaw thrust, Tongue thrust, Yankauer suctioning, Positive pressure oxygen administration, Placement of an oral or nasal airway.

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Respiratory Events Requiring Intervention
17 Participants
2 Participants

SECONDARY outcome

Timeframe: During the first injection of local anesthesia during surgery

To compare the groups regarding movement of the patient during the first injection of local anesthesia during the IVS at time of injection measured using the Behavioral Pain Scale - Non-Intubated patients. The minimum value is 3 and the maximum value is 12. Higher scores mean a worse outcome (i.e., more pain and movement on injection)

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Reaction to Administration of Local Anesthesia
3.9 score on a scale
Standard Deviation 1.5
4.2 score on a scale
Standard Deviation 1.4

SECONDARY outcome

Timeframe: 30 minutes following surgery

Visual Analog Scale was used to measure overall satisfaction with the IV sedation and memory of the procedure. The minimum score is 0 (not satisfied at all) to a maximum score of 100 (completely satisfied). A higher score is a better outcome.

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Patient Satisfaction
93.5 score on a scale
Standard Deviation 10.1
86.6 score on a scale
Standard Deviation 22.0

SECONDARY outcome

Timeframe: 15 minutes following surgery

Surgeon satisfaction was measured by the surgeon grading the "Operating Conditions" scale. The minimum value was 0 and the maximum was 3. 0=very poor, 1=poor, 2=fair, 3=good

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Surgeon Satisfaction - Survey
2.8 score on a scale
Standard Deviation 0.5
2.9 score on a scale
Standard Deviation 0.4

SECONDARY outcome

Timeframe: 15 minutes following surgery

Surgeon satisfaction is measured by the Cooperation Scale. Minimum score of 0 and maximum of 9. Higher indicates a worse outcome (i.e., discomfort and movement)

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Cooperation Scale
2.07 score on a scale
Standard Deviation 1.95
1.47 score on a scale
Standard Deviation 1.68

SECONDARY outcome

Timeframe: During the procedure, up to 40 minutes

To compare the differences in hemodynamic stability using a D/M combination compared to the MFP combination. (In this study, a deviation from baseline of both the blood pressure and heart rate by 20% or greater will be considered clinically significant) a. Change in heart rate (change ≥ 20 BPM)

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Hemodynamic Stability - Heart Rate
77 beats per minute
Standard Deviation 14.20
62 beats per minute
Standard Deviation 12.28

SECONDARY outcome

Timeframe: During the procedure, up to 40 minutes

To compare the differences in hemodynamic stability using a D/M combination compared to the MFP combination. (In this study, a deviation from baseline by 20% or greater will be considered clinically significant) a. Change in blood pressure (NIBP) (change ≥ 20%) Blood pressure is presented as mean arterial pressure

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Hemodynamic Stability - Blood Pressure
78 mm Hg
Standard Deviation 12.4
88 mm Hg
Standard Deviation 9.25

SECONDARY outcome

Timeframe: During the procedure, up to 40 minutes

To assess whether a D/M combination leads to a significant change in respiratory depression compared to the MFP combination. a. Change in respiratory rate (change ≥ 20%)

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Respiratory Depression - Respiratory Rate
18 breaths per minute
Standard Deviation 4.38
18 breaths per minute
Standard Deviation 3.61

SECONDARY outcome

Timeframe: During the procedure, up to 40 minutes

To assess whether a D/M combination leads to a significant change in respiratory depression compared to the MFP combination. a. Change in arterial oxygen saturation (as measured by pulse oximeter) i. number of events of ≤92%

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Respiratory Depression - Oxygen Saturation
98.7 Saturation percent
Standard Deviation 1.03
98.9 Saturation percent
Standard Deviation 0.37

SECONDARY outcome

Timeframe: During the procedure, up to 40 minutes

To assess whether a D/M combination increases postoperative recovery time when compared the MFP combination. a. Duration of procedure will be recorded

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Postoperative Recovery Time - Duration of Procedure
24.2 MINUTES
Standard Deviation 13.9
22.1 MINUTES
Standard Deviation 8.8

SECONDARY outcome

Timeframe: After the procedure until ambulation, up to 20 minutes

To assess whether a D/M combination increases postoperative recovery time when compared the MFP combination. a. Time to ambulation (to recovery room) will be recorded

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Postoperative Recovery Time - Ambulation
10.8 minutes
Standard Deviation 8.6
11.6 minutes
Standard Deviation 6.4

SECONDARY outcome

Timeframe: After the procedure until discharge, up to 45 minutes

To assess whether a D/M combination increases postoperative recovery time when compared the MFP combination. a. Time to discharge or "virtual discharge" (comparative statistic) - Aldrete score of ≥ 9 or pre-procedure score is met The minimum score is 0 and the maximum score is 10. A higher score indicates wakefulness, hemodynamically stable, and able to ambulate. ii. All subjects are required to stay a minimum of 30 minutes after the end of the procedure. Therefore, at least two postoperative vital sign readings will be obtained. If the subject meets discharge criteria prior to 30 minutes, this time will be the "virtual discharge" time

Outcome measures

Outcome measures
Measure
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination. Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination. Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
Postoperative Recovery Time - Time to Discharge
26.5 minutes
Standard Deviation 14.9
29.9 minutes
Standard Deviation 12.9

Adverse Events

Propofol Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Dexmedetomidine Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Patrick Nolan

Montefiore Medical Center

Phone: 718-405-8195

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place